Cargando…
Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence
BACKGROUND: Cervical cancer is a predominantly human papillomavirus (HPV)‐driven disease worldwide. However, its incidence is unexplainably low in western Asia, including Saudi Arabia. Using this paradigm, we investigated the role of HPV infection rate and host genetic predisposition in TP53 G72C si...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485004/ https://www.ncbi.nlm.nih.gov/pubmed/28393355 http://dx.doi.org/10.1002/cncr.30635 |
_version_ | 1783245984413777920 |
---|---|
author | Alsbeih, Ghazi A. Al‐Harbi, Najla M. Bin Judia, Sara S. Khoja, Hatim A. Shoukri, Mohamed M. Tulbah, Asma M. |
author_facet | Alsbeih, Ghazi A. Al‐Harbi, Najla M. Bin Judia, Sara S. Khoja, Hatim A. Shoukri, Mohamed M. Tulbah, Asma M. |
author_sort | Alsbeih, Ghazi A. |
collection | PubMed |
description | BACKGROUND: Cervical cancer is a predominantly human papillomavirus (HPV)‐driven disease worldwide. However, its incidence is unexplainably low in western Asia, including Saudi Arabia. Using this paradigm, we investigated the role of HPV infection rate and host genetic predisposition in TP53 G72C single nucleotide polymorphism (SNP) presumed to affect cancer incidence. METHODS: Patients treated between 1990 and 2012 were reviewed, and a series of 232 invasive cervical cancer cases were studied and compared with 313 matched controls without cancer. SNP was genotyped by way of direct sequencing. HPV linear array analysis was used to detect and genotype HPV in tumor samples. RESULTS: The incidence of cervical cancer revealed bimodal peaks at 42.5 years, with a slighter rebound at 60.8 years. Among all cases, 77% were HPV‐positive and 16 HPV genotypes were detected—mostly genotypes 16 (75%) and 18 (9%)—with no difference by age, histology, or geographical region. Although the TP53 G72C genotype was not associated with overall cervical cancer risk, it was significantly associated with HPV positivity (odds ratio, 0.57; 95% confidence interval, 0.36‐0.90; P = .016). Furthermore, the variant C allele was significantly overtransmitted in the population (P < .0003). CONCLUSION: Cervical cancer incidence displays bimodal curve peaking at a young age with secondary rebound at older age. The combination of relative low HPV infection and variant TP53 72C allele overtransmission provide a plausible explanation for the low incidence of cervical cancer in our population. Therefore, HPV screening and host SNP genotyping may provide more relevant biomarkers to gauge the risk of developing cervical cancer. Cancer 2017;123:2459–66. © 2017 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society. This is an open access article under the terms of the Creative Commons Attribution NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
format | Online Article Text |
id | pubmed-5485004 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-54850042017-07-11 Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence Alsbeih, Ghazi A. Al‐Harbi, Najla M. Bin Judia, Sara S. Khoja, Hatim A. Shoukri, Mohamed M. Tulbah, Asma M. Cancer Original Articles BACKGROUND: Cervical cancer is a predominantly human papillomavirus (HPV)‐driven disease worldwide. However, its incidence is unexplainably low in western Asia, including Saudi Arabia. Using this paradigm, we investigated the role of HPV infection rate and host genetic predisposition in TP53 G72C single nucleotide polymorphism (SNP) presumed to affect cancer incidence. METHODS: Patients treated between 1990 and 2012 were reviewed, and a series of 232 invasive cervical cancer cases were studied and compared with 313 matched controls without cancer. SNP was genotyped by way of direct sequencing. HPV linear array analysis was used to detect and genotype HPV in tumor samples. RESULTS: The incidence of cervical cancer revealed bimodal peaks at 42.5 years, with a slighter rebound at 60.8 years. Among all cases, 77% were HPV‐positive and 16 HPV genotypes were detected—mostly genotypes 16 (75%) and 18 (9%)—with no difference by age, histology, or geographical region. Although the TP53 G72C genotype was not associated with overall cervical cancer risk, it was significantly associated with HPV positivity (odds ratio, 0.57; 95% confidence interval, 0.36‐0.90; P = .016). Furthermore, the variant C allele was significantly overtransmitted in the population (P < .0003). CONCLUSION: Cervical cancer incidence displays bimodal curve peaking at a young age with secondary rebound at older age. The combination of relative low HPV infection and variant TP53 72C allele overtransmission provide a plausible explanation for the low incidence of cervical cancer in our population. Therefore, HPV screening and host SNP genotyping may provide more relevant biomarkers to gauge the risk of developing cervical cancer. Cancer 2017;123:2459–66. © 2017 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society. This is an open access article under the terms of the Creative Commons Attribution NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. John Wiley and Sons Inc. 2017-04-10 2017-07-01 /pmc/articles/PMC5485004/ /pubmed/28393355 http://dx.doi.org/10.1002/cncr.30635 Text en © 2017 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Alsbeih, Ghazi A. Al‐Harbi, Najla M. Bin Judia, Sara S. Khoja, Hatim A. Shoukri, Mohamed M. Tulbah, Asma M. Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence |
title | Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence |
title_full | Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence |
title_fullStr | Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence |
title_full_unstemmed | Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence |
title_short | Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence |
title_sort | reduced rate of human papillomavirus infection and genetic overtransmission of tp53 72c polymorphic variant lower cervical cancer incidence |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485004/ https://www.ncbi.nlm.nih.gov/pubmed/28393355 http://dx.doi.org/10.1002/cncr.30635 |
work_keys_str_mv | AT alsbeihghazia reducedrateofhumanpapillomavirusinfectionandgeneticovertransmissionoftp5372cpolymorphicvariantlowercervicalcancerincidence AT alharbinajlam reducedrateofhumanpapillomavirusinfectionandgeneticovertransmissionoftp5372cpolymorphicvariantlowercervicalcancerincidence AT binjudiasaras reducedrateofhumanpapillomavirusinfectionandgeneticovertransmissionoftp5372cpolymorphicvariantlowercervicalcancerincidence AT khojahatima reducedrateofhumanpapillomavirusinfectionandgeneticovertransmissionoftp5372cpolymorphicvariantlowercervicalcancerincidence AT shoukrimohamedm reducedrateofhumanpapillomavirusinfectionandgeneticovertransmissionoftp5372cpolymorphicvariantlowercervicalcancerincidence AT tulbahasmam reducedrateofhumanpapillomavirusinfectionandgeneticovertransmissionoftp5372cpolymorphicvariantlowercervicalcancerincidence |